Maurizio Bonati is professor of public health at the Istituto di Ricerche Farmacologiche Mario Negri IRCSS in Milan, Italy.
Maurizio Bonati
Professor
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
From this contributor
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
By
Maurizio Bonati
7 May 2019 | 5 min read
Explore more from The Transmitter
Vocal language development in genetically different twins; gaze behavior in face-to-face conversation
Here is a roundup of autism-related news and research spotted around the web for the week of 3 March.
Vocal language development in genetically different twins; gaze behavior in face-to-face conversation
Here is a roundup of autism-related news and research spotted around the web for the week of 3 March.
By
Jill Adams
4 March 2025 | 3 min read
How to communicate the value of curiosity-driven research
The burden of proof is on us—researchers—to explain why what we do is valuable to society.
How to communicate the value of curiosity-driven research
The burden of proof is on us—researchers—to explain why what we do is valuable to society.
By
Anthony Zador
4 March 2025 | 5 min read
Neuroscience Ph.D. programs adjust admissions in response to U.S. funding uncertainty
Some departments plan to shrink class sizes by 25 to 40 percent, and others may inadvertently accept more students than they can afford, according to the leaders of 21 top U.S. programs.
Neuroscience Ph.D. programs adjust admissions in response to U.S. funding uncertainty
Some departments plan to shrink class sizes by 25 to 40 percent, and others may inadvertently accept more students than they can afford, according to the leaders of 21 top U.S. programs.
By
Claudia López Lloreda, Calli McMurray
3 March 2025 | 7 min read